This event has passed.
United Kingdom | MedTech post-Brexit
February 10, 2021 @ 10:00 AM - 11:30 AM
The new British regulations | Following the UK’s departure from the European Union on January 1, 2021, new regulations will be in place for European manufacturers looking to bring medical technology to the UK market.
Interested?
Led by a panel of experts, we explore opportunities and developments in the United Kingdom. The different routes for placing medical products on the British market are discussed, as well as the new laws and regulations that all manufacturers must comply with. After the presentations, there is the possibility to network with the speakers and other participants of the webinar via the Remo platform, hosted by Health ~ Holland.
Programme
- 10.00 – 10.05 Introduction
Els Steiger, Chief Representative, NBSO Manchester - 10.05-10.20 Opportunities in the British Healthcare sector
Neil Ebenezer, Medical Technology Specialist, Department for International Trade
– Trends and opportunities in the British Healthcare sector
– Are there advantages to Brexit for MedTech producers?
– What are the most common routes-to-market? - 10.20 – 10.35 The UK regulatory landscape after Brexit
Alex Mclaughlin, Head of International Trade and Medical Device Regulation, Office for Life Sciences
– UKCA Marking for MedTech devices
– Device Classification
– Conformity Assessment, Notified Bodies, Approved Bodies & Competent Authorities
– Responsible persons and Authorised Representatives - 10.35 – 10.50 Protect your product
Patricia Barclay, International Life Science Laywer, BonAccord
– IP protection and laws
– Distribution agreements
– Licensing deals - 10.50 – 11.30 End of presentations., additional possibility of networking
Join each other at the virtual roundtable talks, discuss with experts and other participants of the event via the NL Health~Holland online platform.
Registration & more info
Organized by
